Reuters broke the news that OxyContin maker Purdue Pharma LP is the unnamed company that surfaced in criminal charging documents filed recently in a probe of illegal kickbacks from drugmakers. Purdue Pharma, which faces U.S. Justice Department probes and sprawling litigation over allegations that it played a central role in the deadly U.S. opioid crisis, is facing new scrutiny in connection with a case unveiled by Vermont federal prosecutors against a San Francisco electronic health records vendor
Reuters first to report OxyContin maker Purdue is ‘Pharma Co X’ in U.S. opioid kickback probe
28 January 2020, 12:00 am. 1 minute
Article Tags
Type: Reuters Best
Sectors: Equities
Regions: Americas
Win Types: Exclusivity
Story Types: Exclusive / Scoop
More of Reuters Best
Reuters exclusively reports Indian sugar mills to close early as rain hits cane supply; sugar futures jump; shares fall
January 29, 2023
Reuters reveals that India may peg gross borrowing under 16 trillion rupees in 2023/24
January 27, 2023